Brief: Epirus Biopharma, Polpharma enter profit-sharing collaboration

Epirus Biopharmaceuticals

14/07/2015 11:00

July 14 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * Epirus Biopharmaceuticals and Polpharma group enter into a multi-product, 
   multi-region, profit-sharing collaboration to advance biosimilar portfolio 
   targeting $6 billion addressable innovator market 
 * Retains commercial rights to Switzerland, Norway, Austria, Belgium, Denmark, 
   Finland, Luxembourg, netherlands,sweden 
 * Says joint management board will oversee the collaboration 
 * Says polpharma group will contribute about $30 million towards clinical 
   development cost 
 * Clinical development costs and eventual operating profit will be split 51 
   percent polpharma group and 49 percent Epirus 
 * Source text for Eikon  ID:nGNXLRMICa  
 * Further company coverage  EPRS.O   
 
 ((Bengaluru Newsroom; +1 646 223 8780))